期刊文献+

雷帕霉素抑制血管紧张素Ⅱ诱导的血管内皮细胞增生(英文) 被引量:2

Inhibition by rapamycin on proliferation of vascular endothelial cells induced by angiotensinⅡ
下载PDF
导出
摘要 目的研究阻断PI3K-p70S6K和Ras-p42/p44MAPK信号通路对血管紧张素Ⅱ(ANGⅡ)诱导的脐静脉内皮细胞(HUVEC)增殖及细胞周期进程的影响。方法ANGⅡ联合不同浓度雷帕霉素刺激体外培养的HUVEC,3H-胸腺嘧啶核苷掺入法和3H-亮氨酸掺入法测定细胞DNA和蛋白质合成,流式细胞术检测细胞周期变化,免疫印迹(Western blot)检测细胞信号蛋白p70S6K (p70 ribosomal protein S6 kinase),ERK2(extracellular signal regulated kinase)及细胞周期蛋白CyclinD1、CyclinA、和CyclinBt表达的变化。结果雷帕霉素抑制ANGⅡ诱导的血管内皮细胞蛋白质和DNA的合成,并呈剂量依赖性,雷帕霉素抑制ANGⅡ诱导的p70S6K和CyclinD1的表达,阻滞细胞于G1期(P<0.01),而不影响ERK2、CyclinA和CyclinBt的表达。结论PI3K-p70S6K信号通路在ANGⅡ诱导的HUVEC增殖及细胞周期进程中起关键作用,雷帕霉素免疫抑制靶点p70S6K可应用于干预血管内皮细胞的增殖。 AIM To investigate the effect of rapamycin on proliferation and cell cycle progression of human umbilical vein endothelial cells(HUVEC) induced by angiotensin Ⅱ (ANG Ⅱ ) in vitro through inhibition of the PI3K-pTOS6K cascade and the Ras-p42/p44^MAPK cascade. METHODS Cultured HUVEC were stimulated by ANG Ⅱ alone or in combination with different concentrations of rapamycin. The cell proliferation was measured by incorporation of ^3H-thymidine and ^3H-leucinne. Cell cycle was analysed by flow cytometry. Expression of pTOS6K, ERK2, cyclinA, cyclinBl and cyclinD1 were detected by Western blots. RESULTS Rapamycin inhibited ANG Ⅱ -induced increase in protein content and DNA synthesis dose dependently. Rapamycin inhibited the expression of p70S6K and cyclinD1, but inducing G1 cell cycle arrest ( P 〈 0.01) without affecting the expression of ERK2, cyclinA and cyclinB1. CONCLUSION p70S6K signaling appears to be important for G1-S phase progression and proliferation in ANG Ⅱ -induced HUVEC. Rapamycin targeted pTOS6K could have great potential in therapeutic intervention in the proliferation of vascular endothelial cells.
出处 《中国临床药学杂志》 CAS 2006年第3期142-146,共5页 Chinese Journal of Clinical Pharmacy
关键词 雷帕霉索 血管紧张素Ⅱ 信号传导 细胞周期蛋白 血管内皮细胞 mpamycin angiotensin Ⅱ signal transduction cell cycle protein vascular endothelial cell
  • 相关文献

参考文献10

  • 1Zahradka P,Litchie B,Helwer G.Transactivation of the insulin-like growth factor-Ⅰ receptor by angiotensin Ⅱ mediates downstream signaling from the angiotensin Ⅱ type 1 receptor to phosphatidylinositol 3-kirase[J].Endocrinology,2004,145(6):2978.
  • 2Laura A,Paola B,Marcella P,et al.mTOR:a protein kinase switching between life and death[J].Pharmacological Research,2004,50(6):545.
  • 3Alexandre C,Claude R,David G,et al.PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival[J].Hepatology,2002,36(5):1079.
  • 4Hafizi S,Wang X,Chester AH,et al.ANG Ⅱ activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells[J].Am JPhysiol Heart Ciro Physiol,2004,287(3):H1232.
  • 5Shang MH,Fang Y,Jun H,et al.Rapamycin inhibits ANGⅡ induced proliferation of vascular endothelial cells[J].Chin J Nephrol,Dialysis Transp,2005,14(2):142.
  • 6Mathews MB,Sonenberg N,Hershey JWB.Origins and principles of translational control[M].//Sonenberg N,Hershey JWB,Mathews MB,eds.Translational control of gene expression.Cold Spring Harbor,NY:Cold Spring Harbor Laboratory Press,2000:p1-31.
  • 7Lekmine F,Uddin S,Sassano A,et al.Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type Ⅰ interferons[J].J Biol Chem,2003,278(30):27772.
  • 8Scassa ME,Guberma AS,Vaione CL.Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin[J].Exp Cell Res,2001,271(2):201.
  • 9Zhao Y,Liu J,Li L,et al.Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin Ⅱ -induced vascular smooth muscle cell proliferation[J].Regul Pept,2005,May 15; 128(1):43.
  • 10Shang MH,Fang Y,Jun H,et al.Rapamycin inhibits ANGⅡ induced proliferation of vascular endothelial cells[J].Chin J Nephrol,Dialysis Transp,2005,14(2):142.

同被引文献26

  • 1尚明花,张树俭,范昱,姚建,徐琴君.肾素—血管紧张素系统在慢性环孢素肾病中的作用[J].中华肾脏病杂志,2006,22(4):243-247. 被引量:3
  • 2Hofma SH,van der Giessen WJ,et al.Indication of long-term endothelial dys-function after sirolimus-elutingstent implantation.Eur Heart J,2006,27:166-170.
  • 3Meier P,Zbinden R,et al.Coronary collateral function long after drug-elutingstent implantation.J Am Coll Cardiol,2007,49:15-20.
  • 4Luscher TF,Steffel J,et al.Drug-eluting stent and coronary thrombosis:bio-logical mechanisms and clinical implications.Circulation,2007,115:1051-8.
  • 5Stepkowski SM,Chen H,et al.Rapamycin,a potent immunosuppressivedrug for vascularized heart,kidney,and small bowel transplantation in the rat[J] .Transplantation,1991,51(1):22-26.
  • 6Mourad G,Vela C,et al.Long-term improvement in renal function after cy-closporine reduction in renal transplant recipients with histologically proven chron-ic cyclosporine nephropathy[J] .Transplantation,1998,65(5):661-667.
  • 7Abraham RT,Wiederrecht GJ,et al.Immunopharmacology of rapamycin[J] .Annu Rev Immunol,1996,14:483-510.
  • 8Yatscoff RW,Wang P,et al.Rapamycin:distribution,pharmacokinetics,and therapeutic range investigations[J] .Ther Drug Monit,1995,17(6):666-671.
  • 9Serkova N,Hausen B,et al.Tissue distribution and clinical monitoring ofthe novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkeylung transplant recipients:interaction with cyclosporine[J] .J Pharmacol ExpTher,2000,294(1):323-332.
  • 10Long C,Cook LG,et al.Removal of FKBP12/12.6 from endothelial ryanodinereceptors leads to an intracellular calcium leak and endothelial dysfunction.Arte-rioscler Thromb Vasc Biol,2007,27:1580-6.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部